Keyphrases
Fluorescence in Situ Hybridization
100%
Chronic Lymphocytic Leukemia
69%
Multiple Myeloma
67%
Non-Hodgkin Lymphoma
38%
B-CLL
34%
B Cells
30%
Chemotherapy
26%
Suppressor Cells
26%
Trisomy 9
26%
Trisomy 8
26%
B-cell Lymphoma 2 (Bcl-2)
26%
Trisomy 12
26%
Essential Thrombocythemia
23%
In Situ Hybridization
23%
Lymphoma
22%
Hodgkin Disease
21%
Leukemia Patients
21%
Lymphocytes
21%
Myeloma
21%
T Cells
21%
Oncogene
20%
Chronic Myeloid Leukemia
19%
Risk Factors
18%
Malignant Lymphoma
18%
Lymphoma Patients
18%
Melphalan
17%
Bone Marrow Involvement
17%
5q31
17%
Alopecia
17%
Long-term Culture
17%
Gene Rearrangement
16%
Polycythemia Vera
16%
Leukemia
16%
Incubation
15%
Intermediate Grade
15%
Monoclonal Gammopathy
14%
Boron Trichloride
14%
Myeloproliferative Neoplasms
14%
Apoptosis
13%
Induced Apoptosis
13%
Interphase nucleus
13%
Fever
13%
Proteinuria
13%
Tumor Protein p53 (TP53)
13%
Gene Replication
13%
Mixed Lymphocyte Reaction
13%
Aberrations
12%
Bone Marrow Examination
12%
Chromosomal Aberrations
12%
Myelodysplastic Syndrome
12%
Medicine and Dentistry
Multiple Myeloma
50%
Hodgkin's Lymphoma
30%
Fluorescence in Situ Hybridization
28%
Non-Hodgkin Lymphoma
26%
B-Cell Chronic Lymphocytic Leukemia
26%
Monoclonal Gammopathy of Undetermined Significance
23%
Melphalan
20%
Lymphoma
20%
T Cell
20%
Gene Rearrangement
17%
Alopecia Mucinosa
17%
Leukemia
17%
Patient with Non-Hodgkins Lymphoma
17%
Light Chain
15%
Acute Myeloid Leukemia
14%
Proteinuria
13%
CD8 Antigen
12%
Bone Marrow Examination
12%
Myeloma
12%
Myelodysplastic Syndrome
12%
Disease
11%
Immunoglobulin Heavy Chain
11%
Cancer
11%
B Lymphocyte
11%
Immunoglobulin G
10%
Paraprotein
10%
Doxorubicin
10%
Alkylating Antineoplastic Agent
10%
Phenotype
9%
Leukemia Cell
9%
Cyclophosphamide
9%
Lymphocyte
9%
Plasma Cell
9%
Symptom
9%
in Situ Hybridization
8%
Interphase
8%
Pleura Effusion
8%
Cannabis Smoking
8%
Neonate
8%
Cesarean Section
8%
Blood Analysis
8%
Cryoglobulinemia
8%
Malignant Neoplasm
8%
Phorbol 13 Acetate 12 Myristate
8%
Normochromic Normocytic Anemia
8%
Lymphocyte Proliferation
8%
Interleukin 6 Receptor
8%
Furazolidone
8%
Immunoblastic Lymphadenopathy
8%
B-Cell Lymphoma
8%